| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $27.98M | $15.66M | $19.42M | $18.67M | $6.15M |
| R&D | $13.42M | $9.71M | $12.26M | $10.23M | $2.75M |
| SG&A | $5.77M | $5.95M | $7.15M | $8.43M | $3.40M |
| Operating Income | -$27.98M | -$15.66M | -$19.42M | -$18.67M | -$6.15M |
| Interest Expense | – | $26.81K | $55.90K | $31.99K | $95.07K |
| Tax Expense | $226.07K | $0.00 | $0.00 | $0.00 | $53.05K |
| Net Income | -$34.66M | -$16.75M | -$18.55M | -$17.56M | -$6.84M |
| EPS (basic) | -52.5900 | -47.1400 | -103.6100 | -1.3500 | -0.8100 |
| EPS (diluted) | -52.5900 | -47.1400 | -103.6100 | -1.3500 | -0.8100 |
| Shares (diluted) | $689.71K | $356.12K | $179.01K | $12.98M | $8.43M |